Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
The device uses optical fibers, photovoltaic cells and a rechargeable battery to address the shortcomings of existing neurostimulation products.
The round equips HeartFlow to accelerate commercialization of its algorithmic, noninvasive test of coronary disease while rolling out new studies.
Simplify Medical raised $23.25 million in a second round of series B funding to support two U.S. pivotal trials of its cervical artificial disc.
The investment equips Rani to step up manufacturing of its robotic, oral biologic delivery pill in anticipation of moving the devices into the clinic.
Zenflow will use the series A funds to trial a minimally invasive device designed to treat urinary symptoms in patients with enlarged prostates.
InVivo Therapeutics, which specializes in spinal cord injuries, names Richard Toselli, M.D., as its president and chief executive.
Boston Scientific released its full-year earnings forecast that fell below Wall Street expectations as the company reiterated its plans to make several more…
The telehealth startup will use the money to grow U.S. sales of its FDA-approved digital stethoscope while working to enter the Chinese market.
The device is designed to enable the remote monitoring of heart failure patients and thereby improve outcomes.
Med-Ally, the maker of active medical devices like the VersaStim neuromodulation platform, said it is moving its operations to Goose Creek in Berkeley County,…